SCHEMBL9874095

SCHEMBL9874095

CC(C)c1nc2c(F)nnc(O)c2n1Cc1ccc(-c2ccccc2C(=O)O)cc1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9873915 0.93 PPARG (0.51) PPARG
SCHEMBL9873994 0.92 PPARG (0.48) PPARG
SCHEMBL9873748 0.90 AGTR1 (0.48) PPARG
SCHEMBL9874681 0.90 PPARG (0.48) PPARG
SCHEMBL9873749 0.90 PPARG (0.46) PPARG
SCHEMBL9873871 0.89 PPARG (0.46) PPARG
SCHEMBL9874988 0.89 PPARG (0.49) PPARG
SCHEMBL9874939 0.88 PPARG (0.47) PPARG
SCHEMBL9873363 0.87 PPARG (0.51) PPARG
SCHEMBL9874913 0.87 PPARG (0.46) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991019715-A1 1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-26 WO disclosed